TekCyte

37 posts

TekCyte banner
TekCyte

TekCyte

@TekCyte

World-leading developer and manufacturer of advanced medical coatings.

Mawson Lakes, South Australia Katılım Aralık 2019
35 Takip Edilen64 Takipçiler
TekCyte
TekCyte@TekCyte·
@TekCyte is very excited by Cynata's (@cynatastemcells) interim results. We hope that one day our combined technologies can help reduce the impact of diabetic foot ulcers (DFU) on the quality of life of diabetes sufferers. #diabetes, #chronicwounds, #stemcells
Cynata Therapeutics@cynatastemcells

We have conducted an initial analysis of wound surface area in our Phase 1 clinical trial of CYP-006TK for diabetic foot ulcers, with promising results. Read about it here: cynata.com/cyp-asx-announ… #stemcells #diabetes #ClinicalTrials

English
0
0
1
52
TekCyte retweetledi
CureCell
CureCell@CureCell3·
JOIN US online to hear an update from the 3 outstanding #youngscientists CureCell has supported this year at our inaugural Annual Showcase on 22 Nov 2pm AEST + we'll tell you about CureCell's ambitious plans for 2023 🙂 Register for our free event: eventbrite.com/e/2022-annual-…
English
0
1
2
0
ChrisBursill
ChrisBursill@ChrisBursill·
So excited and grateful to receive a @heartfoundation Vanguard grant that will support research with @AndrewAbell20 and @ProfKhPeter testing a targeted approach to boosting antioxidant defenses in plaques @SAHMRI_Heart @CNBPscience @UniofAdelaide
Heart Foundation@heartfoundation

We're excited to announce our 2022 research funding portfolio! The Heart Foundation will be supporting 59 research projects, investing a total of $13.25 million into fighting the no.1 cause of death in Australia - heart disease. Read more about the projects and recipients 👇

English
9
1
72
0
TekCyte retweetledi
pfeifer1982
pfeifer1982@pfeifer1982·
CYP-006TK in Adults With Diabetic Foot Ulcers utilizing @TekCyte's heptylamine plasma polymer-coated silicone dressing is currently recruiting 30 patients in a P1 trial. W primary & secondary outcomes being 24 weeks, but still further trials needed. tinyurl.com/2p9enwya
English
1
1
1
0
TekCyte
TekCyte@TekCyte·
Our Chair, Leanna Read has been honoured by the @UniofAdelaide with the honorary degree of Doctor of the University. Well done, Leanna and so well deserved for your tireless efforts in research, government and the biotech industry in SA and Australia.
English
0
0
8
0
TekCyte
TekCyte@TekCyte·
Leanna’s tireless efforts serving the Australian Biotech industry is an inspiration for as all. We at @TekCyte and @Carina are very fortunate to be drawing on her expertise and guidance.
Carina Biotech@CarinaBiotech

Along with our friends at @TekCyte, we send our congratulations to our wonderful Chair and colleague, Dr Leanna Read, recipient of @UniofAdelaide's Distinguished Alumni Award 2021. Very proud of Leanna and grateful for all she brings to our companies youtube.com/watch?v=HXzxPi…

English
0
0
6
0
TekCyte
TekCyte@TekCyte·
@cynatastemcells We're very excited by the prospect of this trial and the potential impact of our combined technologies
English
0
0
0
0
Cynata Therapeutics
Cynata Therapeutics@cynatastemcells·
A great milestone with @TekCyte! The clinical trial of our active wound dressing has received human ethics approval and the trial in 30 patients with diabetic foot ulcers is expected to commence later this year. tekcyte.com/cypatch/
English
1
3
14
0
TekCyte
TekCyte@TekCyte·
Congratulations to TekCyte’s Research Scientist and T-cell specialist Dr Mona Elsemary who graduated from @UniversitySA with her PhD today. Celebrating here with fellow TekCyte staff @Louise_Biomat and Sameer Al-Bataineh who as UniSA adjunct staff were part of the procession.
TekCyte tweet media
English
0
0
3
0
TekCyte
TekCyte@TekCyte·
@CarinaBiotech @AdAlta1AD Great to see two Australian companies joining forces to develop the next generation of cancer therapies
English
0
1
2
0

Keşfet

@cynatastemcells @UniversitySA @ChrisBursill @heartfoundation @AndrewAbell20 @ProfKhPeter @SAHMRI_Heart @CNBPscience